181P Efficacy of eribulin mesylate in HER2-low metastatic breast cancer (MBC): Results from a pooled analysis of two phase III studies
| Autor: | Twelves, C.J., Cortés, J., Kaufman, P.A., Awada, A.H., Im, S-A., Hauck, W., Greenfield, I., Xie, R., Vahdat, L.T. |
|---|---|
| Zdroj: | In Annals of Oncology May 2022 33 Supplement 3:S210-S211 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|